Trial Profile
Study of impaired fatty acid oxidation capacity by dynamic liver scintigraphy with 123I-Bmipp
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Iodofiltic acid I 123 (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Diagnostic use; Therapeutic Use
- 30 Jul 2018 New trial record
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018